Rankings
▼
Calendar
DFTX Q3 2017 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
Q3 2017 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
-$5,644
Operating Income
-$222,535
Net Income
-$513,449
EPS (Diluted)
$-1.67
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$175,180
Free Cash Flow
-$69,600
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$4M
Total Liabilities
$456,191
Stockholders' Equity
$4M
Cash & Equivalents
$3,977
← FY 2017
All Quarters
Q4 2017 →
